Guaifenesin, Dextromethorphan Hydrobromide Tablets

Guaifenesin, Dextromethorphan Hydrobromide Tablets
SPL v4
SPL
SPL Set ID 40288ecf-043d-eb9e-e063-6394a90ac0a7
Route
ORAL
Published
Effective Date 2025-10-01
Document Type 34390-5 HUMAN OTC DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
Guaifenesin (400 mg) Dextromethorphan (20 mg)
Inactive Ingredients
Magnesium Stearate Maltodextrin Povidone K30 Hypromelloses Sodium Starch Glycolate Type A Polyethylene Glycol 400 Microcrystalline Cellulose Croscarmellose Sodium Silicon Dioxide

Identifiers & Packaging

Pill Appearance
Imprint: ET16 Shape: oval Color: white Size: 16 mm Score: 1
Marketing Status
OTC MONOGRAPH DRUG Active Since 2021-01-13

Description

FOR FURTHER MANUFACTURING, PROCESSING OR REPACKING


Medication Information

Warnings and Precautions

KEEP OUT OF THE REACH OF CHILDREN,FOR FURTHER MANUFACTURING, PROCESSING OR REPACKING

Indications and Usage

cough cold, allergic

Dosage and Administration

Description

FOR FURTHER MANUFACTURING, PROCESSING OR REPACKING

Section 50565-1

KEEP OUT OF THE REACH OF CHILDREN

Section 51727-6

Colloidal Silicon Di oxide USP/NF, Hypromellose 5 [ Hydroxy propyl methyl cellulose - E5] USP, Hypromellose 15 Hydroxy propyl methylcellulose E-15 USP, Magnesium stearate. USP/NF, Maltodextrin USP/NF, Microcrystalline cellulose (PH-102) USP/NF, Polyethylene glycol 400 USP/NF, Polyvinyl pyrrolidone (PVPK 30) USP, Sodium starch glycolate Type-A USP/NF, Stearic acid powder

Section 51945-4

Section 55105-1

FOR FURTHER MANUFACTURING, PROCESSING OR REPACKING


Structured Label Content

Indications and Usage (34067-9)

cough cold, allergic

Dosage and Administration (34068-7)

Warnings and Precautions (34071-1)

KEEP OUT OF THE REACH OF CHILDREN,FOR FURTHER MANUFACTURING, PROCESSING OR REPACKING

Section 50565-1 (50565-1)

KEEP OUT OF THE REACH OF CHILDREN

Section 51727-6 (51727-6)

Colloidal Silicon Di oxide USP/NF, Hypromellose 5 [ Hydroxy propyl methyl cellulose - E5] USP, Hypromellose 15 Hydroxy propyl methylcellulose E-15 USP, Magnesium stearate. USP/NF, Maltodextrin USP/NF, Microcrystalline cellulose (PH-102) USP/NF, Polyethylene glycol 400 USP/NF, Polyvinyl pyrrolidone (PVPK 30) USP, Sodium starch glycolate Type-A USP/NF, Stearic acid powder

Section 51945-4 (51945-4)

Section 55105-1 (55105-1)

FOR FURTHER MANUFACTURING, PROCESSING OR REPACKING


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)